This is not the most recent version of the article. View current version (1 NOV 2014)

Intervention Protocol

You have free access to this content

Imiquimod for anogenital warts in non-immunocompromised adults

  1. Carlos F Grillo-Ardila1,*,
  2. Hernando G Gaitán2,
  3. Edith Angel-Müller3,
  4. Ariel I Ruiz-Parra2,
  5. Anne Lethaby4

Editorial Group: Cochrane Sexually Transmitted Infections Group

Published Online: 28 FEB 2013

DOI: 10.1002/14651858.CD010389


How to Cite

Grillo-Ardila CF, Gaitán HG, Angel-Müller E, Ruiz-Parra AI, Lethaby A. Imiquimod for anogenital warts in non-immunocompromised adults (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No.: CD010389. DOI: 10.1002/14651858.CD010389.

Author Information

  1. 1

    National University of Colombia, Department of Obstetrics & Gynecologic and Clinical Research Institute, Bogota, Colombia

  2. 2

    National University of Colombia, Department of Obstetrics & Gynecology and Clinical Research Institute, Faculty of Medicine, Bogota, Colombia

  3. 3

    National University of Colombia, Department of Obstetrics & Gynecology, Bogota, Colombia

  4. 4

    University of Auckland, Obstetrics and Gynaecology, Auckland, New Zealand

*Carlos F Grillo-Ardila, Department of Obstetrics & Gynecologic and Clinical Research Institute, National University of Colombia, Carrera 30 No 45-03, Bogota, Colombia. cfgrilloa@unal.edu.co.

Publication History

  1. Publication Status: New
  2. Published Online: 28 FEB 2013

SEARCH

This is not the most recent version of the article. View current version (01 NOV 2014)

References

Additional references

Berman 2012
  • Berman B, Wolf J. The role of imiquimod 3.75% cream in the treatment of external genital warts. Skin Therapy Letters 2012;17(4):5-7. [PUBMED: 22491804]
Buck 1998
  • Buck HW. Imiquimod (Aldara cream). Infectious Diseases in Obstetrics and Gynecology 1998;6(2):49-51. [PUBMED: 9702584]
Dockrell 2001
Egger 1997
Garland 2002
Grillo 2008
  • Grillo CF, Martinez MY,  Morales B. Molecular aspects of human papillomavirus and cervical cancer [Virus del papiloma humano: aspectos moleculares y cáncer de cérvix]. Revista Colombiana de Obstetricia y Ginecologia 2008;59(4):310-5.
Harbord 2006
Higgins 2011
  • Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.. Available from www.cochrane-handbook.org.
Ho 1998
Kodner 2004
Marini 2002
Maw 2000
Maw 2004
Mayeaux 2008
Miller 1999
  • Miller RL, Gerster JF, Owens ML, Slade HB, Tomai MA. Imiquimod applied topically: a novel immune response modifier and new class of drug. International Journal of Immunopharmacology 1999;21(1):1-14. [PUBMED: 10411278]
Review Manager (RevMan)
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2001.
Schon 2007
Stockfleth 2012
von Krogh 2000
  • von Krogh G, Lacey CJ, Gross G, Barrasso R, Schneider A. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sexually Transmitted Infections 2000;76(3):162-8. [PUBMED: 10961190]
Wagstaff 2007
  • Wagstaff AJ, Perry CM. Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions. Drugs 2007;67(15):2187-210. [PUBMED: 17927284]
Weinstock 2004
Wiley 2002
  • Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, et al. External genital warts: diagnosis, treatment, and prevention. Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America 2002;35(Suppl 2):S210-24. [PUBMED: 12353208]
Workowski 2010
  • Workowski K, Berman S, Centers for Disease Control and Prevention (CDC). Sexually Transmitted Diseases Treatment Guidelines. MMWR Recommended Reports 2010;59(RR-12):69-74. [PUBMED: 21160459]